LIVE WebinarTuesday, January 18th, 202111:30 AM – 12:30 PM Eastern TimeEnroll NowResearchers modeling growths in cell culture need a strategy that faithfully recapitulates the genomic complexity, drug resistance, and metastatic homes of cancer. To do so, they develop organoid cultures that match the attributes of patient-derived growth xenografts and utilize them for economical, high-throughput drug screening efforts.This Technique Talk will go over the obstacles in breast cancer research and treatment and how to establish brand-new techniques and resources for practical accuracy medication and cancer drug development.Learning ObjectivesHow to develop genomically-diverse breast cancer organoidsUsing organoids to screen FDA-approved drugs for cancer treatmentHow to develop an accuracy medicine platform in oncologyEnroll NowMeet the Instructor: Alana L. Welm, PhDSenior Director of Basic ScienceRalph E. and Willia T. Main Presidential Endowed Chair in Cancer ResearchHuntsman Cancer InstituteProfessor, Oncological SciencesUniversity of UtahTSU Sponsored By.
